Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects.
Müller P, Flesch G, de Gasparo M, Gasparini M, Howald H. Müller P, et al. Among authors: howald h. Eur J Clin Pharmacol. 1997;52(6):441-9. doi: 10.1007/s002280050317. Eur J Clin Pharmacol. 1997. PMID: 9342579 Clinical Trial.
Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects.
Müller P, Cohen T, de Gasparo M, Sioufi A, Racine-Poon A, Howald H. Müller P, et al. Among authors: howald h. Eur J Clin Pharmacol. 1994;47(3):231-45. doi: 10.1007/BF02570503. Eur J Clin Pharmacol. 1994. PMID: 7867676 Clinical Trial.
A dose-response curve for Ang II was obtained for each subject before and at 2, 4, 6, 8 and 24 h after administration of placebo and of the two doses of valsartan. ...
A dose-response curve for Ang II was obtained for each subject before and at 2, 4, 6, 8 and 24 h after administration of placebo and …
Arterial and endocrine effects of a combination of an angiotensin converting enzyme inhibitor and a vasodilator in normotensive healthy volunteers.
Brunel P, Guyene TT, Howald H, Ménard J. Brunel P, et al. Among authors: howald h. J Cardiovasc Pharmacol. 1991 Aug;18(2):175-81. doi: 10.1097/00005344-199108000-00001. J Cardiovasc Pharmacol. 1991. PMID: 1717776 Clinical Trial.
Blood pressure (BP), heart rate, humeral artery diameter (D), carotid-femoral pulse-wave velocity (PWV), finger-pulse ratio (FPR), and plasma active renin (PAR) were measured at baseline and every 2 h over 8 h. ...
Blood pressure (BP), heart rate, humeral artery diameter (D), carotid-femoral pulse-wave velocity (PWV), finger-pulse ratio (FPR), and plasm …
Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
Czendlik CH, Sioufi A, Preiswerk G, Howald H. Czendlik CH, et al. Among authors: howald h. Eur J Clin Pharmacol. 1997;52(6):451-9. doi: 10.1007/s002280050318. Eur J Clin Pharmacol. 1997. PMID: 9342580 Clinical Trial.
Circulatory counter-regulations induced by continuous administration of nitroglycerin.
Imhof PR, Rennwald D, Müller P, Howald H, Burkart F. Imhof PR, et al. Among authors: howald h. Methods Find Exp Clin Pharmacol. 1989 Jun;11(6):409-14. Methods Find Exp Clin Pharmacol. 1989. PMID: 2501598 Clinical Trial.
In a placebo-controlled, double-blind, cross-over study in seven healthy volunteers, continuous transdermal administration of nitroglycerin over 48 h by means of Nitroderm TTS 10 evoked counter-regulations that interfered with the nitrate effects. ...The attenuation of the …
In a placebo-controlled, double-blind, cross-over study in seven healthy volunteers, continuous transdermal administration of nitroglycerin …
Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine.
Waldmeier PC, Graf T, Germer M, Feldtrauer JJ, Howald H. Waldmeier PC, et al. Among authors: howald h. Biol Psychiatry. 1993 Mar 1;33(5):373-9. doi: 10.1016/0006-3223(93)90327-a. Biol Psychiatry. 1993. PMID: 8471696 Clinical Trial.
Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration.
Sioufi A, Sandrenan N, Godbillon J, Trunet P, Czendlik C, Howald H, Pfister C, Ezzet F. Sioufi A, et al. Among authors: howald h. Biopharm Drug Dispos. 1997 Aug;18(6):489-97. doi: 10.1002/(sici)1099-081x(199708)18:6<489::aid-bdd36>3.0.co;2-p. Biopharm Drug Dispos. 1997. PMID: 9267682 Clinical Trial.
The use of transdermal nicotine in smoking cessation.
Müller P, Abelin T, Ehrsam R, Imhof P, Howald H, Mauli D. Müller P, et al. Among authors: howald h. Lung. 1990;168 Suppl:445-53. doi: 10.1007/BF02718163. Lung. 1990. PMID: 2117147 Clinical Trial.
Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction.
Bircher AJ, Czendlik CH, Messmer SL, Müller P, Howald H. Bircher AJ, et al. Among authors: howald h. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 1):994-6. doi: 10.1016/s0091-6749(96)80018-2. J Allergy Clin Immunol. 1996. PMID: 8939165 No abstract available.
128 results
Jump to page
Feedback